Search

The article presents insurance coverage for the purchase vehicle to create a coverage plan for specific needs. These include liability coverage to reduce possibility of financial ruin, personal injury protection for medical and lost income from an automobile accident and towing coverage and roadside assistance.

The article discusses how doctors are deciding which patients should continue to be treated with Plavix, a drug used to prevent blood clots in patients who are at risk for heart attacks and strokes. The U.S. Food and Drug Administration (FDA) placed a black box warning on the medication due to a genetic variation in a minority of patients which may prevent the drug from working.

The article discusses various article related to the U.S. Affordable Care Act, purchasing of health insurance, and increasing enrollment in Obama care health insurance plans, published in previous issues of the periodical.

The article presents questions and answers related to insurance coverage for homes including factors that go into pricing home ownership, coverage features, and ways to keep coverage affordable.

The article discusses the acquisition of a voucher held by BioMarin Pharmaceuticals Inc. by pharmaceutical companies Regeneron Pharmaceuticals Inc. and Sanofi SA in an effort to hasten the U.S. Food and Drug Administration's (FDA's) regulatory review of the cholestoral drug alirocrumab as of July 2014.

The article discusses genetic sequencing and the work of teenage cancer patient Elana Simon in 2014 in helping scientists discover a genetic abnormality which may be the cause of the fibrolamellar hepatocellular carcinoma form of cancer that Simon was diagnosed with at age 12.

The article reports that the U.S. National Institutes of Health is embarking upon a project aimed at establishing whether sequencing infants' DNA is more effective than existing methods at screening them for assorted life-threatening or life-impairing diseases.

Reports on the evidence presented by researchers that Boston Scientific Corp. is emerging as rival to Johnson & Johnson in the anticipated market for drug-coated stents to treat heart patients.

Reveals that patients who report to the hospital on the verge of a major heart attack fare much better when they are given high technology cardiac care. Details on a study conducted in the United States; Percentage of patients who died because of a conservative approach to cardiac treatment; Description of the technology used in cardiac treatment.

Reports the American patients killed each year because of medical mistakes while they are in the hospital. Implication of the report; Estimated total costs of preventable mistakes that lead to death; How the American Hospital Association consider the study.

Reveals the differences in treatment of whites and Afro-Americans who suffered from kidney diseases in the United States. Less availability of kidney-transplant operation to African-American patients; Results of studies on the racial bias.